Paracetamol Extra

Quick links to important sections

Paracetamol Extra

Selected form

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Paracetamol Extra

Quick Facts

Property Description
Active ingredient Acetaminophen (Paracetamol), Ascorbic Acid (Vitamin C)
Form Oral solid formulation (e.g., tablet, capsule, effervescent)
Pharmacological class Analgesic-Antipyretic combination
General purpose Symptomatic treatment of pain and fever
Type Fixed-dose combination product

Paracetamol Extra: Defining the Analgesic-Vitamin Combination

Paracetamol Extra is an Over-The-Counter (OTC) fixed-dose combination preparation classified as an Analgesic-Antipyretic with an essential Vitamin Supplement component for systemic use. The core formulation combines Acetaminophen (Paracetamol) and Sodium Ascorbate (source of Ascorbic Acid). This specific dual-component structure is commercially utilized in various markets worldwide to create supportive fever and pain relief products, often differentiating them from simple, single-ingredient analgesics. This combination is clinically recognized across numerous regulatory jurisdictions for its role as a non-opioid pain reliever that acts primarily within the Central Nervous System.

Composition and Differentiation: Acetaminophen and Ascorbic Acid

The preparation's primary function is derived from the synthetic compound Acetaminophen, while the Sodium Ascorbate component ensures the simultaneous delivery of Ascorbic Acid (Vitamin C). The inclusion of the vitamin is a key differentiating factor, positioning the product as a supportive formulation. Pharmacological studies have confirmed the viability and stability of Acetaminophen when combined with Ascorbic Acid in these oral solid formulations. Combinations involving simple analgesics and Ascorbic Acid are recognized for supportive care during certain acute conditions. The combination is thus designed to provide both relief from acute symptoms and general physiological support.

General Therapeutic Purpose and Functional Benefit

The general purpose of this combination is the symptomatic treatment of common acute discomfort, focusing on the simultaneous pain relief and fever reduction. A typical use scenario involves managing the sudden onset of general body aches and fever. The Acetaminophen component directly addresses these two primary symptoms by influencing the thermoregulatory center and modulating pain signals. As a fixed-dose combination with the vitamin, it provides a comprehensive approach designed to support the body's general welfare while effectively managing discomfort and fever.

Regulatory References

  1. Acetaminophen: MedlinePlus Drug Information

What side effects are possible with Paracetamol Extra?

Possible Side Effects and Safety Information

The safety profile for Paracetamol Extra, combining Acetaminophen (Paracetamol) and Ascorbic Acid, is formally documented by regulatory authorities. The profile primarily focuses on the risks associated with the analgesic component, particularly concerning dose limits and potential toxicity.

Adverse Reaction Scope and Classification

Adverse reactions are formally classified based on frequency as observed in official safety data. Rare effects (affecting 1 to 10 users in 10,000) include certain blood disorders like agranulocytosis and general hypersensitivity reactions. Very Rare effects (affecting fewer than 1 in 10,000 users) include severe immune and skin reactions such as anaphylaxis and severe cutaneous adverse reactions (SCARs).

Side effects are categorized by the systems they affect. These System-Organ Classes include Hepatobiliary Disorders (concerning the liver), Immune System Disorders, Blood and Lymphatic System Disorders, and Skin and Subcutaneous Tissue Disorders.

Serious Adverse Reactions and Constraints

The most serious risk documented in regulatory labeling is Acute Liver Failure, which is strongly associated with exceeding the maximum total daily dose of Acetaminophen. Other serious documented reactions include Severe Cutaneous Adverse Reactions (e.g., Stevens-Johnson Syndrome) and Anaphylactic Shock.

Safety constraints are explicitly defined for specific populations. Use is formally contraindicated in individuals with severe active liver disease. Caution is also required for those with severe renal insufficiency and G6PD deficiency, as these conditions may increase the risk of certain adverse effects. The risk of dose-related hepatotoxicity is tied to long-term high-dose exposure, which may also be associated with nephropathy (kidney damage).

Overdose and Emergency Response

Overdose and When to Seek Help

The overdose profile for Paracetamol Extra is defined by the toxic potential of its Acetaminophen component, which can lead to severe and potentially fatal liver damage (hepatotoxicity). This life-threatening risk is officially documented in government regulatory sources.

Documented Overdose Manifestations

Manifestation Description in Regulatory Sources
Initial Symptoms May include nausea, vomiting, anorexia, diaphoresis (sweating), and general malaise.
Timeframe of Damage Signs of severe liver injury often have a delayed onset, becoming apparent 24 to 48 hours or more following the overdose event.

Mandated Emergency Action

Regulatory guidance stresses that the decision to seek help must not be based on the presence or absence of symptoms.

  • Immediate Action Required: You must seek immediate medical attention and contact a poison control center immediately if overdose is suspected, regardless of how the person feels.
  • Antidote and Monitoring: The specific antidote, N-acetylcysteine (NAC), is documented for treatment, but its efficacy is highly time-sensitive. Management requires hospital monitoring, including laboratory tests to measure plasma acetaminophen concentrations and assess liver function.
  • Increased Risk Factors: Individuals with pre-existing conditions like chronic alcoholism or hepatic impairment are officially noted as having an increased risk for severe injury.

The official profile establishes that suspected ingestion of a potentially toxic amount requires immediate emergency contact to mitigate the potential for delayed, life-threatening complications.

Therapeutic Uses of Paracetamol Extra

What Paracetamol Extra Treats: Main Uses and Benefits

The primary purpose of Paracetamol Extra, combining an analgesic-antipyretic with Vitamin C, is to provide effective symptomatic support and relief across specific acute symptom domains. The core ingredient, Acetaminophen (Paracetamol), is widely recognized for its role in temporarily relieving pain and reducing fever associated with numerous conditions, including headaches, backaches, and colds and flu symptoms.

This medication is commonly used across conditions presenting with acute symptomatic discomfort and symptoms related to heightened physiological activity, such as muscle aches and general body malaise. The combination is relevant when supportive symptom management is appropriate, as it contributes to easing the overall symptom load when symptoms that interfere with daily functioning become more noticeable. The inclusion of Vitamin C supports general well-being during symptomatic phases, assisting the patient during episodes of heightened discomfort.

The medication is applied in addressing symptoms associated with acute or episodic changes and is relevant when symptoms become more noticeable.

“The primary goal is to address symptom clusters that may become intense or disruptive, helping patients cope more steadily with temporary illness.”


Quick Fact: Therapeutic Domain: Pain and Fever Management

Eligibility and Restrictions for Use

The use of Paracetamol Extra (Acetaminophen and Ascorbic Acid) is defined by mandatory population eligibility rules set by health authorities, ensuring use is restricted to individuals without specific risk factors.

Contraindicated Populations

Individuals with known hypersensitivity to paracetamol, ascorbic acid, or any excipient must not use this medicine. The product is strictly contraindicated in patients with severe hepatic impairment or severe renal impairment due to the established risk of toxicity related to the primary active substance.

Age-Related and Conditional Use

Use is generally approved for adults and adolescents. For specific combination strengths, the product is often not recommended for children under a mandated minimum age (e.g., 16 years). Conditional use applies to populations with specific risk factors, including those with mild to moderate hepatic or renal impairment, chronic alcoholism, or chronic malnutrition.

Pregnancy and Lactation Status

Regulatory assessments confirm that use is generally permitted during pregnancy and lactation. It is classified as an acceptable analgesic option when administered at the lowest effective dose for the shortest duration possible, aligning with general standards for medication use in these populations.

Eligibility Classifications Regulatory documents establish eligibility boundaries based on physiological reserve and hypersensitivity, distinguishing between absolute Contraindication and cautionary Conditional Use.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents define specific interaction patterns for the components of Paracetamol Extra, primarily Acetaminophen.

Documented Interaction Patterns

Category Interacting Substances and Outcomes
Exposure Modification Co-administration with Probenecid is officially documented to reduce Acetaminophen clearance, resulting in increased drug concentration. Substances like Cholestyramine decrease Acetaminophen absorption.
Toxicity Risk The risk of Acetaminophen-induced hepatotoxicity is officially heightened when co-administered with certain enzyme inducers (e.g., Carbamazepine, Phenobarbital) or in the presence of chronic alcohol consumption.
Pharmacodynamic Effects Prolonged daily use of high-dose Acetaminophen may potentiate the effect of Oral Anticoagulants, leading to an enhanced hypoprothrombinemic effect.

Official Restrictions and Administration Timing

There is a formal restriction against co-administration with other Acetaminophen-containing products to prevent exceeding maximum dosage limits. For substances that reduce absorption, such as Cholestyramine, official instructions require a minimum separation of at least one hour between doses. Furthermore, high-carbohydrate meals are documented to reduce the rate and extent of Acetaminophen absorption. Interaction risks associated with enzyme-inducing agents and alcohol are formally noted as heightened in patients with hepatic impairment and chronic alcohol users.

Mechanism of Action

Central Prostaglandin Signaling Inhibition

The primary action of Acetaminophen is the weak, yet selective, inhibition of Cyclooxygenase ( COX) enzymes within the Central Nervous System ( CNS). By reducing the synthesis of Prostaglandin E2 ( PGE2) in the brain and spinal cord, the mechanism reduces the sensitization of nociceptors and resets the elevated set-point in the hypothalamic thermoregulatory center. This CNS action directly targets the PGE2 signal that elevates the hypothalamic temperature set-point. By lowering PGE2 levels, the drug functionally resets the elevated set-point, which initiates the body’s natural heat-loss mechanisms, such as vasodilation and sweating, facilitating the downward adjustment of core thermal status.

Ascorbic Acid's Antioxidant Mechanism

The Ascorbic Acid component provides complementary support by engaging a distinct mechanistic domain: cellular integrity. Acting as an antioxidant, it helps neutralize free radicals and mitigate oxidative stress that can accompany acute physiological changes. This non-pharmacodynamic contribution mitigates cellular oxidative stress, acting as a cofactor in fundamental physiological processes.

Dosage and Administration Information

Official Administration Guidelines

This section outlines the usage, dosing, and administration protocols for Paracetamol Extra (Acetaminophen/Ascorbic Acid combination).

Administration Scope

Feature Official Guideline
Route of Administration The preparation is licensed for oral route ingestion, consistent with its powder for solution and solid formulation forms.
Dosing Schedule (Adults) Standard single dose is typically 1000 mg of Paracetamol. The absolute maximum daily dose from all sources must not exceed 4000 mg in 24 hours.
Preparation Requirements Powder forms must be fully dissolved in hot water to create the oral solution prior to ingestion.
Dosing Frequency Doses must be separated by a minimum interval of 4 hours, taken as required for symptoms.
Pediatric Rules The combination is generally not recommended for use in children under 12 years of age.
Hepatic Adjustment For patients with chronic hepatic impairment or alcoholism, the daily maximum should be reduced to 2000 mg (2 grams).

Connection to the Overall Use Protocol

The official use protocol is structured around oral dosage and frequency constraints, guiding intermittent administration for short-term symptomatic use. These instructions establish a defined maximum limit and minimum interval between doses, which are followed to ensure adherence to the standard. This protocol is further defined by the requirement for specific preparation steps for certain formulations and by the critical restriction against co-administering any other product containing the Paracetamol component.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Paracetamol Extra


Evidence for Managing General Mild-to-Moderate Pain and Fever

Research describing the core analgesic component (Acetaminophen/Paracetamol) of this medication relies on Systematic Reviews and Meta-analyses. These studies were applied in research contexts involving outcomes related to physical discomfort and temporary physiological strain. Research examined patient populations, including Adults experiencing various forms of acute pain, such as headaches, and Pediatric patients (children) with fever.

The primary focus was to understand short-term symptom changes through the measurement of pain relief scores and reductions in body temperature. Studies examined and monitored patterns of change in pain intensity and fever levels over defined time intervals, typically observed across the few hours immediately following a dose.

Evidence for Symptomatic Relief in Acute Conditions (Colds and Flu)

The use of this medication in conditions associated with acute or disruptive episodes, such as colds and flu-like illnesses, was studied for its application in acute symptom clusters. These studies, which include Randomized Controlled Trials (RCTs), explored the combination’s potential influence on symptom clusters associated with common upper respiratory conditions. Research examined outcomes related to physical discomfort, such as body aches and headache, and assessed the overall duration of illness symptoms in observed populations.

Comparative Study Focus and Research Gaps

Limited information exists from studies comparing the fixed-dose combination directly against the single analgesic ingredient to specifically assess a potential for a distinct added effect for general pain and fever. The research base for the analgesic component is supported by a substantial volume of evidence. However, comparative evidence is lacking regarding the potential added effect of the fixed-dose combination over the single analgesic ingredient in terms of acute symptom relief.

Long-term effects are not fully established. There is limited information for outcomes related to continuous or repeated use over extended time periods. Furthermore, there is variability in the quality of evidence across studies, particularly regarding the supportive component (Ascorbic Acid), and findings were mixed regarding the activity of Ascorbic Acid in the studies of established colds.

Frequently Asked Questions (FAQ)

Common questions about Paracetamol Extra (FAQ)


Q: Are there any official comparisons between Paracetamol Extra and other similar over-the-counter pain relievers?

Official product information indicates that research evidence is limited regarding comparative studies of the fixed-dose combination directly against the single analgesic ingredient (paracetamol alone). The documents do not include detailed comparative studies against other distinct classes of non-paracetamol pain relievers.

Q: How quickly can a person typically expect Paracetamol Extra to begin working?

Studies have examined the changes in symptoms, such as pain intensity and fever levels, that occur after taking the medicine. These patterns of change are typically observed across the few hours immediately following a dose.

Q: What is the generally expected duration of the effects of Paracetamol Extra?

Official administration guidance is structured around a defined interval, which means individual doses are designed to be separated by a minimum of 4 hours. This framework is used for intermittent administration of the product as needed for symptoms.

Q: Is it official guidance to take Paracetamol Extra with food, or does that not matter?

Regulatory documents note that the rate and extent of absorption of the Acetaminophen component can be reduced by high-carbohydrate meals. This indicates that the presence of certain types of food may affect how the medicine is absorbed by the body.

Q: What are the most frequently listed side effects of Paracetamol Extra in product information documents?

Official safety data formally classifies adverse reactions but focuses on detailing the less common effects, such as the Rare (affecting 1 to 10 users in 10,000) and Very Rare (fewer than 1 in 10,000) reactions. The provided summaries do not list the most common or frequent side effects.

Q: Can Paracetamol Extra interact with over-the-counter cold and flu preparations?

Yes, official documents include a formal restriction against co-administering this product with any other medicine containing the Acetaminophen (Paracetamol) component. The restriction means awareness of the ingredients in all co-administered cold and flu preparations is required to ensure the maximum daily dose is not exceeded.

Q: What types of pain is Paracetamol Extra typically indicated to treat?

The general purpose of this combination is the symptomatic treatment of common acute discomfort. This application focuses on simultaneous pain relief and fever reduction for symptoms such as headache and general body aches.

Q: Is Paracetamol Extra considered suitable for treating muscle aches?

Research has examined the medication’s use for managing various physical discomforts associated with acute conditions. This includes the application for symptom clusters that feature general body aches.

Q: Why is the 'Extra' component (Ascorbic Acid) included in this product?

Official documents clarify that this product is a fixed-dose combination of Acetaminophen and Ascorbic Acid (Vitamin C). The inclusion of the vitamin component is described as a key differentiating factor, positioning the product as a supportive formulation.

Q: Can individuals with a known sensitivity to caffeine use Paracetamol Extra?

According to the product information, the 'Extra' component in this specific formulation is Ascorbic Acid (Vitamin C), not caffeine. Hypersensitivity contraindications are restricted to paracetamol, ascorbic acid, or any excipient in the product.

Q: Are there commonly reported side effects related to the 'Extra' component, such as nervousness or jitters?

The 'Extra' component is Ascorbic Acid, described as an antioxidant for cellular support. The documented adverse reactions focus primarily on risks associated with the analgesic component, such as liver or immune system disorders, rather than specific effects like nervousness or jitters.

Q: What is the evidence theme regarding the effectiveness of combining paracetamol and caffeine?

The product described in the official documents is the combination of Acetaminophen and Ascorbic Acid. Research evidence and product labeling are based on this specific formulation, which does not contain caffeine.

How should Paracetamol Extra be stored and disposed of?

Storage Conditions

Official regulations require Paracetamol Extra tablets to be stored below 25 C or 30 C (depending on the specific label) and be protected from light and moisture. To maintain stability until the expiry date, the product must be kept in its original container, which should be tightly closed at all times. All medication must be securely stored out of the sight and reach of children to prevent accidental ingestion.

Disposal Instructions

Do not dispose of unused or expired Paracetamol Extra by flushing it down a toilet or sink, or by placing it in household rubbish. Unused medicine must be returned to a local pharmacy or designated medicinal waste collection point for proper disposal. This procedure ensures the safe destruction of the product according to local regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Paracetamol Extra found in:

A-Z Index: